FDA OKs First New Drug in Years for Sickle Cell - Diverse Health

Higher Education News and Jobs

FDA OKs First New Drug in Years for Sickle Cell

Email
   
        


by Dr. Tyeese L. Gaines

The U.S. Food and Drug Administration approved a new drug on Friday that reduces the complications associated with sickle cell disease — the first drug approved for the blood disorder in more than 20 years.

The drug, called Endari, consists of L-glutamine, which is an amino acid, and is approved for sickle cell patients five years and older.

Read More

Comments

Print Friendly

Related Articles

Bill Would Expand Care for Veterans Republican Georgia Sen. Johnny Isakson has proposed legislation to increase access to privatized medical coverage for American veterans paid for by the federal government. Georgia Senator Johnny Isakson, who chairs the committee, looks to accompli...
Trump Thinks Health Insurance Costs Young $12 a Year President Donald Trump has an...interesting conception of how health insurance works. In a new interview with the New York Times, Trump defended his knowledge of health care and the Senate's chaotic attempts to pass a Republican health care bill t...
Nevada Moves to Combat Pot Bottleneck CARSON CITY, Nev. —- Nevada has moved to reduce supply problems at recreational marijuana stores that have faced overwhelming demand for newly legal pot and the possibility of their shelves going empty. Regulators approved emergency rules that wo...
Panel Asks FDA to Review Opioid Safety The U.S. Food and Drug Administration should review the safety and effectiveness of all opioids, and consider the real-world impacts the powerful painkillers have, not only on patients, but also on families, crime and the demand for heroin. That's...